NET PROFIT (x1000 NOK)
EMPLOYEES
Recipharm Stockholm AB
Closing information (x1000 NOK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
0
![]() |
0
![]() |
0 |
Financial expenses |
14
|
2,999
|
5,587 |
Earnings before taxes |
512
|
-812
|
15,463 |
EBITDA |
-371
|
242
|
18,496 |
Total assets |
24,335
|
22,390
|
105,581 |
Current assets |
24,335
|
21,733
|
104,117 |
Current liabilities |
35
|
1,846
|
81,908 |
Equity capital |
24,300
|
20,112
|
21,131 |
- share capital |
101
|
95
|
98 |
Employees (average) |
0
![]() |
0
|
15 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
99.9%
|
89.8%
|
20.0% |
Turnover per employee | 0 | ||
Profit as a percentage of turnover | |||
Return on assets (ROA) |
2.2%
|
9.8%
|
19.9% |
Current ratio |
69528.6%
|
1177.3%
|
127.1% |
Return on equity (ROE) |
2.1%
|
-4.0%
|
73.2% |
Change turnover |
0
![]() |
0
|
-214,069 |
Change turnover % | -100% | ||
Chg. No. of employees |
0
|
-15
|
-119 |
Chg. No. of employees % |
-100%
|
-89% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.